Publications

Publications about Symetis – February 2017

  • Transcatheter aortic valve implantation using the ACURATE TATM system: 1-year outcomes and comparison of 500 patients from the SAVI registries

Börgermann J, Holzhey DM, Thielmann M, Girdauskas E, Schroefel H, Hofmann S et al.,

Eur J Cardiothorac Surg 2017; doi:10.1093/ejcts/ezw423.

  • Transcatheter aortic valve implantation using the ACURATE TA and ACURATE neo valves: a 4-year single-center experience

Hamm, K., Reents, W., Zacher, M., Kerber, S., Diegeler, A., Schieffer, B., Barth, S.             

Eurointervention 2017; Jaa-087 2017, doi:10.4244/EIJ-D-16-00898

  • Early clinical outcomes of a novel self-expanding transapical transcatheter aortic valve bioprosthesis

Chu, M.W. A., Bagur, R., Losenno, K. L., Jones, P. M., Diamantouros, P., Teefy, P., Gelinas, J. J., and Kiaii, B.

The Journal of Thoracic and Cardiovascular Surgery; http://dx.doi.org/10.1016/j.jtcvs.2016.11.054

  • Prospective Comparison Between Three TAVR Devices: ACURATE Neo vs. CoreValve vs. SAPIEN XT. A Single Heart Team Experience in Patients with Severe Aortic Stenosis         

Jatene, T., Castro-Filho, A., Meneguz-Moreno, R. A., Siqueira, D. A., Abizaid, A. A.C., Ramos, A. I.O., Arrais, M., Le Bihan, D. C.S., Barretto, R. B.M., Moreira, A. C., Sousa, A. G.M.R. and Eduardo Sousa, J.

Cathet. Cardiovasc. Intervent. 2016 Dec. doi:10.1002/ccd.26837

  • First North American Experience With the Transfemoral ACURATE neo Self-Expanding Transcatheter Aortic Bioprosthesis

Bagur, R., Teefy, P. J., Kiaii, B., Diamantouros, P. and Chu, M. W.A.

Cathet. Cardiovasc. Intervent. 2016 Sep. doi:10.1002/ccd.26802

  • First-in-man transfemoral transcatheter aortic valve implantation with the ACURATE neo for the treatment of aortic regurgitation.

Toggweiler S, Biaggi P, Grünenfelder J, Reho I, Bühler I, Corti R.

EuroIntervention. 2016 May 17;12(1):78. doi: 10.4244/EIJV12I1A14. No abstract available.

  • Improving outcomes: case-matched comparison of novel second-generation versus first-generation self-expandable transcatheter heart valves.

Schaefer A, Treede H, Schoen G, Deuschl F, Schofer N, Schneeberger Y, Blankenberg S, Reichenspurner H, Schaefer U, Conradi L.

Eur J Cardiothorac Surg. 2016 Aug;50(2):368-73. doi: 10.1093/ejcts/ezw021. Epub 2016 Feb 16.

  • Successful percutaneous implantation of Symetis ACURATE neo transcatheter aortic bioprosthesis for the treatment of pure aortic regurgitation.

Cerillo AG, Griese D, Berti S.

Catheter Cardiovasc Interv. 2016 Aug;88(2):319-23. doi: 10.1002/ccd.26402. Epub 2016 Jan 13.

  • Salvaging lowermost deployment of an ACURATE device during transcatheter aortic valve replacement with balloon and lasso pull techniques.

Corcione N, Biondi-Zoccai G, Giordano A.

Catheter Cardiovasc Interv. 2015 Oct 1. doi: 10.1002/ccd.26252. [Epub ahead of print]

  • Symetis Acurate Neo Transfemoral Aortic Bioprosthesis - Initial Polish Experience.

Zembala M et al.

Kardiol Pol. 2016;74(3):206-12. doi: 10.5603/KP.a2015.0192. Epub 2015 Sep 28.

  • Symetis ACURATE TAVI: Review of the technology, developments and current data with this self-expanding transcatheter heart valve.

Schaefer U, Conradi L, Diemert P, Deuschl F, Schofer N, Seiffert M, Lubos E, Shirmer J, Reichenspurner H, Blankenberg S, and Treede H.

Minerva Cardioangiol. 2015 Oct;63(5):359-69. Epub 2015 Jul 22.

  • Transcatheter ACURATE-TA Aortic Valve Implantation in a Patient With Previous Mechanical Mitral Valve.

Bagur R, Diamantouros P, Teefy P, Kiaii B, Chu M.

Ann Thorac Surg. 2015 Nov; 100(5):e115-7. doi: 10.1016/j.athoracsur.2015.06.116.

  • Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices.

Seiffert M, Fujita B, Avanesov M, Lunau C, Schön G, Conradi L, Prashovikj E, Scholtz S, Börgermann J, Scholtz W, Schäfer U, Lund G, Ensminger S, Treede H.

Eur Heart J Cardiovasc Imaging. 2015 Jul 9. pii: jev174. [Epub ahead of print]

  • Symetis Valve Implantation in Failing Freestyle With Close Proximity Between Coronary Ostia and Annulus.

Nagendran J, Catrip J, Diamantouros P, Teefy P, Kiaii B, Chan I, Goela A, Holzhey D, Chu M.

Ann Thorac Surg 2015; 99:e87–8

  • Single Institution Experience With Transcatheter Valve-in-Valve Implantation Emphasizing Strategies for Coronary Protection.

Camboni D et al.

Ann Thorac Surg 2015;99:1532–8

  • Comparison of two valve systems for transapical aortic valve implantation: a propensity score-matched analysis.

Kempfert J, Meyera A, Kim W.K, Van Linden A, Arsalan M, Blumenstein J, Möllmann H, Walther T.

Eur J Cardiothorac Surg 2015; doi:10.1093/ejcts/ezv042

  • A new self-expanding transcatheter aortic valve for transfemoral implantation – First in Asia implantation of the ACURATE neo/TF system: early results.

Maeda K, Kuratani T, Torikai K, Mizote I, Ichibori Y, Onishi T, Nakatani S, Sakata Y, Toda K, Sawa Y.

Accepted by Circulation on Jan 4th 2015.

  • First registry results from the newly approved ACURATE TA™ TAVI system.

Kempfert J, Holzhey D, Hofmann S, Girdauskas E, Treede H, Schröfel H, Thielmann M, Walther T.

Eur J Cardiothorac Surg. 2015 Jul;48(1):137-41. doi: 10.1093/ejcts/ezu367. Epub 2014 Nov 25.

  • Transapical transcatheter aortic valve implantation using the second-generation self-expanding Symetis ACURATE TA valve.

Huber C, Wenaweser P, Windecker S, Carrel T.

Multimed Man Cardiothorac Surg. 2014 Oct 8;2014. pii: mmu017. doi: 10.1093/mmcts/mmu017.

  • The Self-Expanding Symetis Acurate Does Not Increase Cerebral Microembolic Load When Compared to the Balloon-Expandable Edwards Sapien Prosthesis: A Transcranial Doppler Study in Patients Undergoing Transapical Aortic Valve Implantation.

Erdoes G, Huber C, Basciani R, Stortecky S, Windecker S.

PLoS ONE 9(10): e108191. doi:10.1371/journal.pone.0108191.

  • Expanding the Limits: Transapical Transcatheter Aortic Valve for Severe Aortic Regurgitation.

Wendt DKahlert PPasa SEl-Chilali KAl-Rashid FTsagakis KDohle DSErbel RJakob HThielmann M.

JACC Cardiovasc Interv. 2014 Aug 5. pii: S1936-8798(14)01069-3.

  • Single-centre experience with next-generation devices for transapical aortic valve implantation.

Seiffert M, Conradi L, Kloth B, Koschyk D, Shirmer J, Schnabel RB, Blankenberg S, Reichenspurner H,

Diemert P, and Treede H.

Eur J Cardiothorac Surg 2014 1–7.

  • Symetis Acurate Transapical Aortic Valve: the initial experience with a second generation of transcatheter aortic valve replacement device.

Zembala MO, Piegza J, Wackawski J, et al.

Kardiol Pol. 2014;72(2):187-93.

  • Symetis ACURATE TF™ aortic bioprosthesis.

Möllmann H, Diemert P, Grube E, Baldus S, Kempfert J, Abizaid A.

EuroIntervention 2013;9:S107-S110

  • Symetis Acurate Aortic Valve-in-Valve Implantation for Early Degeneration of a Sapien THV Prosthesis.

Kiefer P, Lehmkuhl,L, Seeburger J, Vollroth M, Noack T, Schro€ter T, Mohr FW, Holzhey D.

Ann Thorac Surg 2013;96:1880.

  • A new self-expandable transcatheter aortic valve for transapical implantation: feasibility in acute and chronic animal experiments.

Wendt DPasa SKahlert PDelaloye SAl-Rashid FPrice VJánosi RABorenstein NBehr LKonorza

TErbel RJakob HThielmann M.

Scand Cardiovasc J. 2013 Jun;47 (3):145-53.

  • Symetis ACURATE TA™ valve – technology and TA90 results.

Kempfert J, Möllmann H, Walther T.

EuroIntervention 2012;8:Q102-Q109.

  • Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes.

Kempfert J, Treede H, Rastan AJ, et al.

Eur J Cardiothorac Surg. 0 (2012) 1-6.

  • Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes.

Kempfert J, Rastan AJ, Beyersdorf F, et al.

Eur J Cardiothorac Surg 2011;40:1114-9.